Association of the VEGF with proliferative Diabetic
Treatment of Proliferative Diabetic Retinopathy with Panretinal Photo Coagulation and Anti VEGF Injection, Depending on the Case
... Proliferative diabetic retinopathy (PDR) is the most common cause of severe visual loss in people with diabetes. Although panretinal photocoagulation (PRP) remains one of the best treatment, it has many ...
6
Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy
... 2013 Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy Khadija Tariq, 1 Saira Bano Malik, 1 Syeda Hafiza Benish Ali, 1,2 ...
9
Original Article Predictive clinical features and efficacy of preoperative anti-VEGF treatment on visual acuity in patients with proliferative diabetic retinopathy
... Received November 2, 2017; Accepted June 9, 2018; Epub July 15, 2018; Published July 30, 2018 Abstract: Objective: To study the efficacy of anti-VEGF therapy for proliferative diabetic retinopathy ...
8
Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy
... advanced proliferative diabetic retinopathy ...and VEGF are elevated after unsuccessful vitrectomy in patients with PDR and to investigate whether the altered levels of these cytokines are associated ...
9
Genome wide association studies for diabetic macular edema and proliferative diabetic retinopathy
... into DME and PDR provided more homogeneous groups for analysis. This study is comparable in size to other published GWAS for DR phenotypes and provides a use- ful breakdown of data from the previously reported composite ...
8
<p>Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy</p>
... of VEGF antagonists will become a major liability on medical fi ...that VEGF antagonists may augment TGF- β expression and increase the numbers of patients with retinal detachment and endophthalmitis after ...
8
Association of Monocyte Chemoattractant Protein 1 (MCP 1) 2518A/G Polymorphism with Proliferative Diabetic Retinopathy in Korean Type 2 Diabetes
... in diabetic patients with the ...with diabetic retinopathy re- mains ...for diabetic retinopathy in a Japanese population of dia- betic ...with diabetic retinopathy in a group of Japanese pa- ...
5
Plasma metabolomic profiling of proliferative diabetic retinopathy
... Finally, 4 metabolites were selected as candidate biomarkers for PDR, namely, fumaric acid, uridine, acetic acid, and cytidine. The area under the curve for these biomarkers were 0.96, 0.95, 1.0, and 0.95, respectively. ...
11
Different lasers and techniques for proliferative diabetic retinopathy
... The Diabetic Retinopathy Study (DRS) demonstrated that laser photocoagulation of the retina reduced se- vere visual loss (defined as visual acuity of 5/200 or less on two con- secutive visits at least four months ...
17
Different lasers and techniques for proliferative diabetic retinopathy.
... However it is important to note that both the DRCR.net protocol S and CLARITY studies included diabetic participants predomi- nantly without high-risk characteristics (HRC) of PDR. This has implications in drawing ...
108
Characterisation of the vitreous proteome in proliferative diabetic retinopathy
... There are two main limitations to this study. First, the gel electrophoresis technique has a number of signifi- cant drawbacks. These include its inability to detect low-abundance proteins in the presence of high-abun- ...
11
A case of pseudoxanthoma elasticum with proliferative diabetic retinopathy
... Patients with angioid streaks that do not extend to the macula can be followed-up, but treatment is necessary if CNV develops. If the CNV does not involve the macula, local laser photocoagulation can be performed, but ...
5
Proliferative Diabetic Retinopathy: An Overview of Vitreous Immune and Biomarkers
... increase VEGF production and remove physical barriers to new vessel growth [58, ...stress. Diabetic patients often have increased MMP, mainly MMP-9 and MMP-2 in the retina and ...many diabetic ...
23
Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
... indicate association after ad- justing for age, sex, non-proliferative retinopathy, prior anti-VEGF therapy and rhegmatogenous retinal ...positive association, and negative value indicates ...
10
Serum vitamin D is a biomolecular biomarker for proliferative diabetic retinopathy
... tes Association (ADA) guidelines which include fasting plasma glucose level ≥ 126 mg/dl, 2 h plasma glucose level ≥ 200 mg/dl during an oral glucose tolerance test ...respectively. Diabetic retinopathy was ...
5
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
... of systemic blood pressure or cerebrovascular accident (CVA) (Wu 2008). Why it is important to do this review Despite the standard of care given for the prevention and treat- ment of DR, it remains an important cause of ...
80
Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
... With a multiplex bead immunoassay, levels of 11 chemokines and growth factors were measured from the undiluted vitreous sample from each patient. In the non-PDR eyes, the levels of the 11 chemokines and growth factors ...
10
Osteoprotegerin is a new regulator of inflammation and angiogenesis in proliferative diabetic retinopathy
... Although OPG was first described as a modulator of bone metabolism, an increasing number of reports now consider OPG also has a function in other biological systems, including promotion of angiogenesis and ...
13
Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes
... Abstract Diabetic retinopathy is one of the leading causes of blindness in working-age ...individuals. Diabetic patients with proteinuria or those on dialysis usually present severe forms of diabetic ...
7
Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
... Pathologic angiogenesis relies on the aberrant activation of proteases and various degratory enzymes emanating from the endothelium that allow for endothelial cells to leave the parental vasculature and proliferate in ...
11